| Investor | Rtw Investments, Lp |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Rtw Investments, Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G/A | VSTM / Verastem, Inc. | 7,836,346 | 9,018,724 | ||||
| 2026-05-15 | 13G/A | QURE / uniQure N.V. | 3,711,462 | 2,586,356 | ||||
| 2026-05-15 | 13G/A | TENX / Tenax Therapeutics, Inc. | 650,968 | 1,867,630 | ||||
| 2026-05-15 | 13G/A | TSHA / Taysha Gene Therapies, Inc. | 23,407,133 | 20,689,084 | ||||
| 2026-05-15 | 13G | TNGX / Tango Therapeutics, Inc. | 13,300,620 | |||||
| 2026-05-15 | 13G/A | STOK / Stoke Therapeutics, Inc. | 5,310,033 | 5,940,866 | ||||
| 2026-05-15 | 13G/A | REPL / Replimune Group, Inc. | 6,395,732 | 7,356,916 | ||||
| 2026-05-15 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 1,637,165 | 0 | ||||
| 2026-05-15 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 9,155,168 | 12,356,953 | ||||
| 2026-05-15 | 13G | IRTC / iRhythm Holdings, Inc. | 1,668,500 | |||||
| 2026-05-15 | 13G/A | IMTX / Immatics N.V. | 11,433,354 | 12,869,340 | ||||
| 2026-05-15 | 13G | ERAS / Erasca, Inc. | 16,157,175 | |||||
| 2026-05-15 | 13G/A | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 9,474,397 | 12,971,571 | ||||
| 2026-05-15 | 13G | CGON / CG Oncology, Inc. | 6,984,808 | |||||
| 2026-05-15 | 13G | IPSC / Century Therapeutics, Inc. | 13,043,478 | |||||
| 2026-05-15 | 13G | CELC / Celcuity Inc. | 3,039,621 | |||||
| 2026-05-15 | 13G/A | CSTL / Castle Biosciences, Inc. | 2,115,237 | 2,758,335 | ||||
| 2026-05-15 | 13G | CADL / Candel Therapeutics, Inc. | 6,422,018 | |||||
| 2026-05-15 | 13G/A | BBNX / Beta Bionics, Inc. | 2,500,000 | 2,000,000 | ||||
| 2026-05-15 | 13G/A | APLS / Apellis Pharmaceuticals, Inc. | 7,666,764 | 3,685,045 | ||||
| 2026-04-29 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 11,942,426 | 11,942,394 | ||||
| 2026-03-02 | 13D/A | ALUR / Allurion Technologies Inc. | 5,891,430 | 5,891,430 | ||||
| 2026-02-25 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 8,306,063 | 11,942,426 | ||||
| 2026-02-17 | 13G | ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) | 22,913,720 | 69,590,320 | ||||
| 2026-02-17 | 13G/A | VSTM / Verastem, Inc. | 5,626,803 | 7,836,346 | ||||
| 2026-02-17 | 13G/A | QURE / uniQure N.V. | 4,424,968 | 3,711,462 | ||||
| 2026-02-17 | 13G/A | TENX / Tenax Therapeutics, Inc. | 418,440 | 650,968 | ||||
| 2026-02-17 | 13G/A | TSHA / Taysha Gene Therapies, Inc. | 25,183,287 | 23,407,133 | ||||
| 2026-02-17 | 13G/A | SABS / SAB Biotherapeutics, Inc. | 1,024,335 | 1,587,302 | ||||
| 2026-02-17 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 11,764,000 | 1,637,165 | ||||
| 2026-02-17 | 13G | RDNT / RadNet, Inc. | 3,938,500 | |||||
| 2026-02-17 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 5,315,514 | 5,059,053 | ||||
| 2026-02-17 | 13G/A | ORKA / Oruka Therapeutics, Inc. | 1,945,649 | 2,058,148 | ||||
| 2026-02-17 | 13G | KLRS / Kalaris Therapeutics, Inc. | 1,300,000 | |||||
| 2026-02-17 | 13G/A | IMTX / Immatics N.V. | 8,815,617 | 11,433,354 | ||||
| 2026-02-17 | 13G/A | XGN / Exagen Inc. | 1,696,866 | 1,148,768 | ||||
| 2026-02-17 | 13G | CSTL / Castle Biosciences, Inc. | 2,115,237 | |||||
| 2026-02-17 | 13G/A | BBNX / Beta Bionics, Inc. | 3,299,869 | 2,500,000 | ||||
| 2026-02-17 | 13G/A | APGE / Apogee Therapeutics, Inc. | 2,712,097 | 2,712,097 | ||||
| 2026-02-17 | 13G | APLS / Apellis Pharmaceuticals, Inc. | 7,666,764 | |||||
| 2026-02-17 | 13G/A | ALEC / Alector, Inc. | 6,990,806 | 0 | ||||
| 2026-02-17 | 13G/A | AKRO / Akero Therapeutics, Inc. | 5,873,308 | 0 | ||||
| 2025-11-14 | 13G/A | ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) | 55,368,760 | 22,913,720 | ||||
| 2025-11-14 | 13G | XNCR / Xencor, Inc. | 6,221,054 | |||||
| 2025-11-14 | 13G/A | QURE / uniQure N.V. | 5,158,231 | 4,424,968 | ||||
| 2025-11-14 | 13G | REPL / Replimune Group, Inc. | 6,395,732 | |||||
| 2025-11-14 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 5,640,593 | 9,155,168 | ||||
| 2025-11-14 | 13G/A | MRUS / Merus N.V. | 4,169,393 | 2,025,277 | ||||
| 2025-11-14 | 13G/A | IMTX / Immatics N.V. | 6,540,540 | 8,815,617 | ||||
| 2025-11-14 | 13G/A | CRGX / CARGO Therapeutics, Inc. | 3,055,063 | 0 | ||||
| 2025-11-14 | 13G | AQST / Aquestive Therapeutics, Inc. | 6,250,000 | |||||
| 2025-11-14 | 13G | ALEC / Alector, Inc. | 6,990,806 | |||||
| 2025-11-14 | 13G/A | ACAD / ACADIA Pharmaceuticals Inc. | 8,705,501 | 7,144,524 | ||||
| 2025-11-13 | 13D/A | ALUR / Allurion Technologies Inc. | 4,035,142 | 5,891,430 | ||||
| 2025-11-07 | 13D/A | ALUR / Allurion Technologies Inc. | 2,542,603 | 4,035,142 | ||||
| 2025-10-29 | 13D/A | RNAM / Avidity Biosciences, Inc. | 12,079,734 | 4,686,110 | ||||
| 2025-08-14 | 13G/A | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 7,877,349 | 9,474,397 | ||||
| 2025-08-14 | 13G/A | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 7,877,349 | 0 | ||||
| 2025-08-14 | 13G | ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock) | 55,368,760 | |||||
| 2025-08-14 | 13G/A | VSTM / Verastem, Inc. | 4,245,476 | 5,626,803 | ||||
| 2025-08-14 | 13G/A | QURE / uniQure N.V. | 4,265,428 | 5,158,231 | ||||
| 2025-08-14 | 13G/A | TSHA / Taysha Gene Therapies, Inc. | 20,673,307 | 25,183,287 | ||||
| 2025-08-14 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 3,152,341 | 3,424,180 | ||||
| 2025-08-14 | 13G/A | XGN / Exagen Inc. | 1,504,602 | 1,696,866 | ||||
| 2025-08-14 | 13G/A | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 7,877,349 | 9,474,397 | ||||
| 2025-08-14 | 13G/A | CRGX / CARGO Therapeutics, Inc. | 5,941,456 | 3,055,063 | ||||
| 2025-08-14 | 13G/A | AXSM / Axsome Therapeutics, Inc. | 2,922,729 | 1,516,903 | ||||
| 2025-08-14 | 13G/A | AKRO / Akero Therapeutics, Inc. | 6,859,823 | 5,873,308 | ||||
| 2025-08-06 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 8,306,063 | 8,306,063 | ||||
| 2025-05-15 | 13G | TENX / Tenax Therapeutics, Inc. | 418,440 | |||||
| 2025-05-15 | 13G/A | ETNB / 89bio, Inc. | 7,378,548 | 1,967,527 | ||||
| 2025-05-15 | 13G/A | GHRS / GH Research PLC | 3,327,129 | 5,499,769 | ||||
| 2025-05-15 | 13G/A | PEPG / PepGen Inc. | 3,193,097 | 0 | ||||
| 2025-05-15 | 13G/A | DYN / Dyne Therapeutics, Inc. | 5,218,641 | 1,690,567 | ||||
| 2025-05-15 | 13G | BBNX / Beta Bionics, Inc. | 3,299,869 | |||||
| 2025-05-15 | 13G/A | AXSM / Axsome Therapeutics, Inc. | 4,051,365 | 2,922,729 | ||||
| 2025-05-15 | 13G | VSTM / Verastem, Inc. | 4,245,476 | |||||
| 2025-05-15 | 13G | QURE / uniQure N.V. | 4,265,428 | |||||
| 2025-05-15 | 13G | RAPT / RAPT Therapeutics, Inc. | 11,764,000 | |||||
| 2025-05-15 | 13G | CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) | 7,877,349 | |||||
| 2025-05-15 | 13G | ORKA / Oruka Therapeutics, Inc. | 1,945,649 | |||||
| 2025-05-15 | 13G/A | IMUX / Immunic, Inc. | 5,594,479 | 1,026,762 | ||||
| 2025-05-15 | 13G/A | TSHA / Taysha Gene Therapies, Inc. | 12,368,334 | 20,673,307 | ||||
| 2025-05-01 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 7,704,030 | 8,306,063 | ||||
| 2025-04-17 | 13D/A | ALUR / Allurion Technologies Inc. | 1,050,053 | 2,542,603 | ||||
| 2025-02-24 | 13D/A | ALUR / Allurion Technologies Inc. | 3,666,589 | 1,050,053 | ||||
| 2025-02-14 | 13G/A | CUTRQ / Cutera, Inc. | 1,817,585 | 0 | ||||
| 2025-02-14 | 13G/A | GERN / Geron Corporation | 44,111,916 | 0 | ||||
| 2025-02-14 | 13G/A | AXSM / Axsome Therapeutics, Inc. | 4,489,596 | 4,051,365 | ||||
| 2025-02-14 | 13G/A | SYRE / Spyre Therapeutics, Inc. | 2,232,760 | 3,621,996 | ||||
| 2025-02-14 | 13G/A | SAGE / Sage Therapeutics, Inc. | 5,197,019 | 3,002,370 | ||||
| 2025-02-14 | 13G/A | IMTX / Immatics N.V. | 10,000,000 | 6,540,540 | ||||
| 2025-02-14 | 13G/A | TSHA / Taysha Gene Therapies, Inc. | 18,505,556 | 12,368,334 | ||||
| 2025-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 3,261,496 | 1,113,002 | ||||
| 2025-02-14 | 13G | APGE / Apogee Therapeutics, Inc. | 2,712,097 | |||||
| 2025-02-14 | 13G/A | SABS / SAB Biotherapeutics, Inc. | 9,220,672 | 1,024,335 | ||||
| 2025-02-14 | 13G | PEPG / PepGen Inc. | 3,193,097 | |||||
| 2025-02-14 | 13G/A | NGNE / Neurogene Inc. | 1,135,256 | 1,498,829 | ||||
| 2025-02-14 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 3,354,825 | 5,640,593 | ||||
| 2025-02-14 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 2,494,138 | 2,822,216 | ||||
| 2025-02-14 | 13G/A | ACAD / ACADIA Pharmaceuticals Inc. | 13,707,506 | 8,705,501 | ||||
| 2025-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 4,131,045 | 5,310,033 | ||||
| 2025-02-14 | 13G/A | AKRO / Akero Therapeutics, Inc. | 5,919,435 | 6,859,823 | ||||
| 2025-02-14 | 13G/A | DYN / Dyne Therapeutics, Inc. | 6,818,641 | 5,218,641 | ||||
| 2025-01-29 | 13D/A | ALUR / Allurion Technologies Inc. | 1,050,053 | |||||
| 2025-01-16 | 13D/A | ALUR / Allurion Technologies Inc. | 1,050,060 | |||||
| 2025-01-10 | 13D/A | ALUR / Allurion Technologies Inc. | 277,797 | |||||
| 2024-12-16 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 18,188,457 | |||||
| 2024-11-14 | 13G/A | ARVN / Arvinas, Inc. | 4,213,483 | 2,782,329 | ||||
| 2024-11-14 | 13G/A | IMUX / Immunic, Inc. | 4,335,255 | 5,594,479 | ||||
| 2024-11-14 | 13G/A | EPIX / ESSA Pharma Inc. | 2,298,662 | 3,261,496 | ||||
| 2024-11-14 | 13G/A | CRGX / CARGO Therapeutics, Inc. | 5,941,456 | |||||
| 2024-11-14 | 13G/A | AKRO / Akero Therapeutics, Inc. | 3,592,759 | 5,919,435 | ||||
| 2024-11-14 | 13G/A | ACAD / ACADIA Pharmaceuticals Inc. | 11,253,551 | 13,707,506 | ||||
| 2024-11-14 | 13G/A | ETNB / 89bio, Inc. | 5,578,931 | 7,378,548 | ||||
| 2024-11-14 | 13G/A | URGN / UroGen Pharma Ltd. | 1,726,808 | 4,930,204 | ||||
| 2024-11-14 | 13G/A | RARE / Ultragenyx Pharmaceutical Inc. | 6,887,086 | 1,968,002 | ||||
| 2024-11-14 | 13G/A | IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) | 6,096,387 | 4,869,798 | ||||
| 2024-11-14 | 13G | PCSC / Perceptive Capital Solutions Corp | 742,500 | |||||
| 2024-11-14 | 13G | DYN / Dyne Therapeutics, Inc. | 6,818,641 | |||||
| 2024-11-14 | 13G | IMTX / Immatics N.V. | 10,000,000 | |||||
| 2024-11-14 | 13G | MDGL / Madrigal Pharmaceuticals, Inc. | 1,993,687 | |||||
| 2024-11-14 | 13G | MRUS / Merus N.V. | 4,169,393 | |||||
| 2024-11-14 | 13G | GERN / Geron Corporation | 44,111,916 | |||||
| 2024-11-14 | 13G | NGNE / Neurogene Inc. | 1,135,256 | |||||
| 2024-11-14 | 13G/A | VCEL / Vericel Corporation | 3,212,794 | 0 | ||||
| 2024-11-14 | 13G/A | PHAR / Pharming Group N.V. - Depositary Receipt (Common Stock) | 38,496,391 | 0 | ||||
| 2024-11-14 | 13G/A | FULC / Fulcrum Therapeutics, Inc. | 5,469,956 | 0 | ||||
| 2024-11-14 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 3,463,201 | 0 | ||||
| 2024-11-14 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 9,196,186 | 0 | ||||
| 2024-11-14 | 13G/A | ACET / Adicet Bio, Inc. | 4,134,631 | 0 | ||||
| 2024-10-24 | 13D/A | ALUR / Allurion Technologies Inc. | 4,416,587 | 3,666,589 | ||||
| 2024-08-23 | 13D/A | RNAM / Avidity Biosciences, Inc. | 9,659,809 | 12,079,734 | ||||
| 2024-08-07 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 5,620,645 | 7,704,030 | ||||
| 2024-07-02 | 13D/A | ALUR / Allurion Technologies Inc. | 3,936,903 | 4,416,587 | ||||
| 2024-04-17 | 13D/A | ALUR / Allurion Technologies Inc. | 3,457,707 | 3,936,903 | ||||
| 2024-03-01 | 13D/A | RNA / Atrium Therapeutics, Inc. | 6,701,489 | 9,659,809 | ||||
| 2024-02-14 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 4,315,102 | 3,354,825 | ||||
| 2024-02-14 | 13G/A | XGN / Exagen Inc. | 1,364,336 | 1,504,602 | ||||
| 2024-02-14 | 13G/A | MRTX / Mirati Therapeutics, Inc. | 3,643,114 | 0 | ||||
| 2024-02-14 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 5,741,939 | 9,196,186 | ||||
| 2024-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 5,615,387 | 7,423,970 | ||||
| 2024-02-14 | 13G | ACAD / ACADIA Pharmaceuticals Inc. | 11,253,551 | |||||
| 2024-02-14 | 13G | SAGE / Sage Therapeutics, Inc. | 5,197,019 | |||||
| 2024-02-14 | 13G | SYRE / Spyre Therapeutics, Inc. | 2,232,760 | |||||
| 2024-02-14 | 13G | EPIX / ESSA Pharma Inc. | 0 | 2,298,662 | ||||
| 2024-02-14 | 13G | ARVN / Arvinas, Inc. | 4,213,483 | |||||
| 2024-02-14 | 13G | AKRO / Akero Therapeutics, Inc. | 3,592,759 | |||||
| 2024-02-14 | 13G | URGN / UroGen Pharma Ltd. | 1,726,808 | |||||
| 2024-02-14 | 13G | ETNB / 89bio, Inc. | 5,578,931 | |||||
| 2024-02-14 | 13G | PHAR / Pharming Group N.V. - Depositary Receipt (Common Stock) | 38,496,391 | |||||
| 2024-02-14 | 13G | SABS / SAB Biotherapeutics, Inc. | 9,220,672 | |||||
| 2024-02-14 | 13G | GHRS / GH Research PLC | 3,327,129 | |||||
| 2024-02-14 | 13G | TSHA / Taysha Gene Therapies, Inc. | 18,505,556 | |||||
| 2024-02-14 | 13G/A | IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) | 5,559,322 | 6,096,387 | ||||
| 2024-02-14 | 13G/A | IMUX / Immunic, Inc. | 3,861,290 | 4,335,255 | ||||
| 2024-02-14 | 13G/A | FULC / Fulcrum Therapeutics, Inc. | 4,993,279 | 5,469,956 | ||||
| 2024-02-14 | 13G/A | PMVP / PMV Pharmaceuticals, Inc. | 4,356,920 | 0 | ||||
| 2024-02-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 2,067,824 | 0 | ||||
| 2024-02-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 3,591,986 | 5,315,514 | ||||
| 2024-02-14 | 13G/A | RARE / Ultragenyx Pharmaceutical Inc. | 3,966,915 | 6,887,086 | ||||
| 2024-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,870,981 | 4,131,045 | ||||
| 2024-02-14 | 13G/A | VCEL / Vericel Corporation | 3,099,904 | 3,212,794 | ||||
| 2024-02-14 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 2,374,138 | 2,494,138 | ||||
| 2024-02-14 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 3,084,215 | 3,463,201 | ||||
| 2024-02-14 | 13G/A | CCCC / C4 Therapeutics, Inc. | 2,819,472 | 0 | ||||
| 2024-02-14 | 13G/A | BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock) | 3,204,762 | 0 | ||||
| 2024-02-14 | 13G/A | APYX / Apyx Medical Corporation | 3,398,279 | 1,025,963 | ||||
| 2024-02-14 | 13G/A | ACET / Adicet Bio, Inc. | 4,241,472 | 4,134,631 | ||||
| 2024-02-14 | 13G/A | TNYA / Tenaya Therapeutics, Inc. | 2,458,750 | 0 | ||||
| 2024-02-14 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 2,548,125 | 3,152,341 | ||||
| 2024-02-14 | 13G/A | AXSM / Axsome Therapeutics, Inc. | 2,980,482 | 4,489,596 | ||||
| 2024-01-24 | 13D/A | RNA / Atrium Therapeutics, Inc. | 5,956,558 | 6,701,489 | ||||
| 2024-01-19 | 13G | CUTRQ / Cutera, Inc. | 1,846,596 | 1,817,585 | ||||
| 2023-12-12 | 13D/A | DMTKQ / DermTech, Inc. | 3,018,666 | 0 | ||||
| 2023-11-24 | 13G | LYRA / Lyra Therapeutics, Inc. | 5,175,832 | |||||
| 2023-09-19 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 18,188,457 | 18,188,457 | ||||
| 2023-08-11 | 13D | ALUR / Allurion Technologies Inc. | 3,457,707 | |||||
| 2023-05-10 | 13D/A | CUTRQ / Cutera, Inc. | 1,846,596 | 1,846,596 | ||||
| 2023-05-05 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 5,118,512 | 5,620,645 | ||||
| 2023-04-13 | 13D | CUTRQ / Cutera, Inc. | 1,798,675 | 1,846,596 | ||||
| 2023-04-05 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 17,628,567 | 18,188,457 | ||||
| 2023-04-05 | 13D/A | CHAQ / Chardan Healthcare Acquisition 2 Corp | 3,350,803 | 0 | ||||
| 2023-02-14 | 13G/A | CLSD / Clearside Biomedical, Inc. | 3,806,018 | 0 | ||||
| 2023-02-14 | 13G/A | ATHA / LeonaBio, Inc. | 1,906,557 | 0 | ||||
| 2023-02-14 | 13G/A | ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) | 16,250,000 | 0 | ||||
| 2023-02-14 | 13G/A | CTMX / CytomX Therapeutics, Inc. | 6,029,700 | 0 | ||||
| 2023-02-14 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 7,554,817 | 0 | ||||
| 2023-02-14 | 13G/A | BLU / Bellus Health Inc | 5,968,017 | 0 | ||||
| 2023-02-14 | 13G/A | APVO / Aptevo Therapeutics Inc. | 288,236 | 0 | ||||
| 2023-02-14 | 13G/A | PRQR / ProQR Therapeutics N.V. | 7,027,725 | 0 | ||||
| 2023-02-14 | 13G/A | MGNX / MacroGenics, Inc. | 3,975,554 | 0 | ||||
| 2023-02-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 2,186,324 | 2,067,824 | ||||
| 2023-02-14 | 13G/A | TELA / TELA Bio, Inc. | 1,399,686 | 390,364 | ||||
| 2023-02-14 | 13G | RARE / Ultragenyx Pharmaceutical Inc. | 3,966,915 | |||||
| 2023-02-14 | 13G/A | IDYA / IDEAYA Biosciences, Inc. | 2,520,076 | 0 | ||||
| 2023-02-14 | 13G/A | VCEL / Vericel Corporation | 4,517,570 | 3,099,904 | ||||
| 2023-02-14 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 3,921,579 | 3,084,215 | ||||
| 2023-02-14 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 2,013,601 | 2,548,125 | ||||
| 2023-02-14 | 13G | MRTX / Mirati Therapeutics, Inc. | 3,643,114 | |||||
| 2023-02-14 | 13G/A | PMVP / PMV Pharmaceuticals, Inc. | 2,980,960 | 4,356,920 | ||||
| 2023-02-14 | 13G | AXSM / Axsome Therapeutics, Inc. | 2,980,482 | |||||
| 2023-02-14 | 13G/A | ITOS / iTeos Therapeutics, Inc. | 2,353,015 | 0 | ||||
| 2023-02-14 | 13G/A | CCCC / C4 Therapeutics, Inc. | 2,494,965 | 2,819,472 | ||||
| 2023-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,644,248 | 3,870,981 | ||||
| 2023-02-14 | 13G/A | RXDX / Prometheus Biosciences Inc | 3,354,303 | |||||
| 2023-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 2,590,932 | 0 | ||||
| 2023-02-14 | 13G/A | ISEE / IVERIC bio Inc | 6,722,624 | 821,288 | ||||
| 2023-02-14 | 13G/A | IMUX / Immunic, Inc. | 1,715,470 | 3,861,290 | ||||
| 2023-02-14 | 13G/A | JNCE / Jounce Therapeutics Inc | 2,863,198 | 5,106,341 | ||||
| 2023-02-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 2,599,822 | 3,591,986 | ||||
| 2023-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 2,637,192 | 0 | ||||
| 2023-02-14 | 13G/A | FULC / Fulcrum Therapeutics, Inc. | 3,866,872 | 4,993,279 | ||||
| 2023-02-14 | 13G | IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) | 5,559,322 | |||||
| 2023-02-14 | 13G/A | OYST / Oyster Point Pharma Inc | 2,058,504 | 2,304,977 | ||||
| 2023-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 5,293,966 | 5,615,387 | ||||
| 2023-02-14 | 13G/A | CUTR / Cutera, Inc. | 1,397,063 | 1,798,675 | ||||
| 2023-02-14 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 2,319,138 | 2,374,138 | ||||
| 2023-02-14 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 5,810,140 | 5,741,939 | ||||
| 2023-02-14 | 13G/A | PYXS / Pyxis Oncology, Inc. | 2,120,760 | 0 | ||||
| 2023-02-14 | 13G/A | XGN / Exagen Inc. | 821,414 | 1,364,336 | ||||
| 2023-02-14 | 13G/A | ACET / Adicet Bio, Inc. | 3,023,744 | 4,241,472 | ||||
| 2023-02-02 | 13D/A | RNA / Atrium Therapeutics, Inc. | 3,995,000 | 5,956,558 | ||||
| 2023-01-27 | 13D/A | OBIO / Orchestra BioMed Holdings, Inc. | 1,000,000 | 5,118,512 | ||||
| 2022-12-05 | 13G/A | IMVT / Immunovant, Inc. | 8,459,241 | 0 | ||||
| 2022-12-02 | 13G/A | IMVT / Immunovant, Inc. | 7,592,253 | 8,459,241 | ||||
| 2022-11-08 | 13D/A | DMTK / DermTech, Inc. | 3,118,666 | 3,018,666 | ||||
| 2022-11-03 | 13D/A | LABP / Landos Biopharma, Inc. | 3,150,722 | 0 | ||||
| 2022-10-31 | 13D/A | LABP / Landos Biopharma, Inc. | 3,650,722 | 3,150,722 | ||||
| 2022-10-12 | 13D | HSAQ / Health Sciences Acquisitions Corp 2 | 1,000,000 | |||||
| 2022-10-11 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 16,272,635 | 17,628,567 | ||||
| 2022-10-06 | 13D/A | LABP / Landos Biopharma, Inc. | 4,275,722 | 3,650,722 | ||||
| 2022-09-21 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 16,272,635 | 16,272,635 | ||||
| 2022-09-21 | 13D | CHAQ / Chardan Healthcare Acquisition 2 Corp | 2,997,540 | 3,350,803 | ||||
| 2022-02-14 | 13G/A | ABUS / Arbutus Biopharma Corporation | 5,978,355 | 2,504,493 | ||||
| 2022-02-14 | 13G/A | AGEN / Agenus Inc. | 12,864,677 | 5,868,315 | ||||
| 2022-02-14 | 13G/A | LSAQ / LifeSci Acquisition II Corp | 975,000 | 3,975,000 | ||||
| 2022-02-14 | 13G/A | VINC / Vincerx Pharma, Inc. | 750,000 | 741,236 | ||||
| 2022-02-14 | 13G | CCCC / C4 Therapeutics, Inc. | 2,494,965 | |||||
| 2022-02-14 | 13G | TNYA / Tenaya Therapeutics, Inc. | 2,458,750 | |||||
| 2022-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 2,397,378 | 2,590,932 | ||||
| 2022-02-14 | 13G/A | CTMX / CytomX Therapeutics, Inc. | 5,868,326 | 6,029,700 | ||||
| 2022-02-14 | 13G/A | XGN / Exagen Inc. | 1,250,131 | 821,414 | ||||
| 2022-02-14 | 13G | JNCE / Jounce Therapeutics Inc | 2,863,198 | |||||
| 2022-02-14 | 13G | ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) | 16,250,000 | |||||
| 2022-02-14 | 13G | PYXS / Pyxis Oncology, Inc. | 2,120,760 | |||||
| 2022-02-14 | 13G | MGNX / MacroGenics, Inc. | 3,975,554 | |||||
| 2022-02-14 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 7,227,364 | 7,554,817 | ||||
| 2022-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 3,028,719 | 2,637,192 | ||||
| 2022-02-14 | 13G/A | CUTR / Cutera, Inc. | 1,375,663 | 1,397,063 | ||||
| 2022-02-14 | 13G/A | OYST / Oyster Point Pharma Inc | 1,925,594 | 2,058,504 | ||||
| 2022-02-14 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 1,512,673 | 2,186,324 | ||||
| 2022-02-14 | 13G/A | CLSD / Clearside Biomedical, Inc. | 3,958,130 | 3,806,018 | ||||
| 2022-02-14 | 13G/A | IDYA / IDEAYA Biosciences, Inc. | 2,096,843 | 2,520,076 | ||||
| 2022-02-14 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 3,422,855 | 3,921,579 | ||||
| 2022-02-14 | 13G/A | ITOS / iTeos Therapeutics, Inc. | 2,762,791 | 2,353,015 | ||||
| 2022-02-14 | 13G | PMVP / PMV Pharmaceuticals, Inc. | 2,980,960 | |||||
| 2022-02-14 | 13G/A | FULC / Fulcrum Therapeutics, Inc. | 2,071,409 | 3,866,872 | ||||
| 2022-02-14 | 13G/A | TELA / TELA Bio, Inc. | 1,383,816 | 1,399,686 | ||||
| 2022-02-14 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 2,319,138 | 2,319,138 | ||||
| 2022-02-14 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 2,463,601 | 2,013,601 | ||||
| 2022-02-14 | 13G/A | BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock) | 2,206,948 | 3,204,762 | ||||
| 2022-02-14 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 5,387,513 | 5,810,140 | ||||
| 2022-02-14 | 13G | IMUX / Immunic, Inc. | 1,715,470 | |||||
| 2022-02-14 | 13G/A | PRQR / ProQR Therapeutics N.V. | 5,088,493 | 7,027,725 | ||||
| 2022-02-14 | 13G/A | APYX / Apyx Medical Corporation | 3,391,279 | 3,398,279 | ||||
| 2022-02-14 | 13G/A | ATHA / LeonaBio, Inc. | 2,685,779 | 1,906,557 | ||||
| 2022-02-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 3,650,069 | 2,599,822 | ||||
| 2022-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,544,248 | 3,644,248 | ||||
| 2022-02-14 | 13G/A | BLU / Bellus Health Inc | 5,189,862 | 5,968,017 | ||||
| 2022-02-14 | 13G/A | CHAQ / Chardan Healthcare Acquisition 2 Corp | 2,362,540 | 2,997,540 | ||||
| 2022-02-14 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 4,315,201 | 4,315,102 | ||||
| 2022-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 4,968,209 | 5,293,966 | ||||
| 2021-12-15 | 13G | ACET / Adicet Bio, Inc. | 3,023,744 | |||||
| 2021-12-08 | 13G | CTMX / CytomX Therapeutics, Inc. | 5,868,326 | |||||
| 2021-11-03 | 13G | CUTR / Cutera, Inc. | 1,375,663 | |||||
| 2021-09-07 | 13G/A | CHAQ / Chardan Healthcare Acquisition 2 Corp | 1,387,540 | 2,362,540 | ||||
| 2021-08-31 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 16,185,119 | 16,272,635 | ||||
| 2021-07-29 | 13G | CHAQ / Chardan Healthcare Acquisition 2 Corp | 1,387,540 | |||||
| 2021-07-02 | 13G | EPIX / ESSA Pharma Inc. | 3,028,719 | |||||
| 2021-05-18 | 13G | LSAQ / LifeSci Acquisition II Corp | 650,000 | 975,000 | ||||
| 2021-04-06 | 13G/A | PRQR / ProQR Therapeutics N.V. | 5,088,493 | 5,088,493 | ||||
| 2021-04-06 | 13G/A | PRQR / ProQR Therapeutics N.V. | 5,009,768 | 5,088,493 | ||||
| 2021-03-29 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 17,530,044 | 16,185,119 | ||||
| 2021-02-26 | 13G/A | PTCT / PTC Therapeutics, Inc. | 4,221,836 | 4,968,209 | ||||
| 2021-02-16 | 13D | LABP / Landos Biopharma, Inc. | 4,275,722 | |||||
| 2021-02-16 | 13G/A | IMVT / Immunovant, Inc. | 7,592,253 | |||||
| 2021-02-16 | 13G | HLXA / Helix Acquisition Corp - Class A | 750,000 | |||||
| 2021-02-16 | 13G | FREQ / Frequency Therapeutics Inc | 2,461,486 | |||||
| 2021-02-16 | 13G | VINC / Vincerx Pharma, Inc. | 750,000 | |||||
| 2021-02-16 | 13G | LSAQ / LifeSci Acquisition II Corp | 650,000 | |||||
| 2021-02-16 | 13G | US33830X1046 / Five Prime Therapeutics Inc | 2,515,788 | |||||
| 2021-02-12 | 13G/A | ISEE / IVERIC bio Inc | 6,121,882 | 6,722,624 | ||||
| 2021-02-12 | 13G/A | PTCT / PTC Therapeutics, Inc. | 3,832,480 | 4,221,836 | ||||
| 2021-02-12 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 6,386,607 | 7,227,364 | ||||
| 2021-02-12 | 13G/A | FULC / Fulcrum Therapeutics, Inc. | 2,071,409 | 2,071,409 | ||||
| 2021-02-12 | 13G/A | FIXX / Homology Medicines, Inc. | 4,349,250 | 0 | ||||
| 2021-02-12 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 2,032,446 | 2,319,138 | ||||
| 2021-02-12 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 5,874,229 | 7,253,857 | ||||
| 2021-02-12 | 13G/A | COGT / Cogent Biosciences, Inc. | 1,258,750 | 1,998,750 | ||||
| 2021-02-12 | 13G/A | CLSD / Clearside Biomedical, Inc. | 3,750,107 | 3,958,130 | ||||
| 2021-02-12 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 1,885,000 | 3,422,855 | ||||
| 2021-02-12 | 13G/A | XGN / Exagen Inc. | 902,085 | 1,250,131 | ||||
| 2021-02-12 | 13G/A | WVE / Wave Life Sciences Ltd. | 2,414,027 | 0 | ||||
| 2021-02-12 | 13G/A | VCEL / Vericel Corporation | 2,989,429 | 4,517,570 | ||||
| 2021-02-12 | 13G/A | TELA / TELA Bio, Inc. | 1,139,358 | 1,383,816 | ||||
| 2021-02-12 | 13G/A | TBIO / Telesis Bio, Inc. | 3,304,808 | 2,978,427 | ||||
| 2021-02-12 | 13G/A | TARS / Tarsus Pharmaceuticals, Inc. | 2,463,601 | 2,463,601 | ||||
| 2021-02-12 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,544,248 | 3,544,248 | ||||
| 2021-02-12 | 13G/A | BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock) | 1,916,852 | 2,206,948 | ||||
| 2021-02-12 | 13G/A | RLMD / Relmada Therapeutics, Inc. | 1,255,857 | 1,512,673 | ||||
| 2021-02-12 | 13G/A | BLU / Bellus Health Inc | 4,840,992 | 5,189,862 | ||||
| 2021-02-12 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 2,459,988 | 3,650,069 | ||||
| 2021-02-12 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 3,401,434 | 5,387,513 | ||||
| 2021-02-12 | 13G/A | PRQR / ProQR Therapeutics N.V. | 4,779,135 | 5,009,768 | ||||
| 2021-02-12 | 13G/A | ATHA / LeonaBio, Inc. | 2,668,913 | 2,685,779 | ||||
| 2021-02-12 | 13G/A | OYST / Oyster Point Pharma Inc | 1,914,606 | 1,925,594 | ||||
| 2021-02-12 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 3,958,264 | 4,315,201 | ||||
| 2021-02-12 | 13G/A | APYX / Apyx Medical Corporation | 3,391,279 | 3,391,279 | ||||
| 2021-02-12 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 2,551,020 | 2,397,378 | ||||
| 2021-02-12 | 13G/A | APVO / Aptevo Therapeutics Inc. | 290,000 | 288,236 | ||||
| 2021-02-12 | 13G/A | ABUS / Arbutus Biopharma Corporation | 5,666,754 | 5,978,355 | ||||
| 2021-02-12 | 13G/A | AGEN / Agenus Inc. | 13,725,251 | 12,864,677 | ||||
| 2021-02-04 | 13G | ITOS / iTeos Therapeutics, Inc. | 2,762,791 | |||||
| 2021-01-22 | 13G | IDYA / IDEAYA Biosciences, Inc. | 2,096,843 | |||||
| 2021-01-19 | 13D/A | DMTK / DermTech, Inc. | 2,658,627 | 3,118,666 | ||||
| 2021-01-08 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 17,282,324 | 17,530,044 | ||||
| 2020-12-03 | 13G | COGT / Cogent Biosciences, Inc. | 1,258,750 | |||||
| 2020-11-16 | 13G | APVO / Aptevo Therapeutics Inc. | 290,000 | |||||
| 2020-11-13 | 13G | FULC / Fulcrum Therapeutics, Inc. | 2,071,409 | |||||
| 2020-10-26 | 13G | TARS / Tarsus Pharmaceuticals, Inc. | 2,463,601 | |||||
| 2020-09-28 | 13G | ATHA / LeonaBio, Inc. | 2,668,913 | |||||
| 2020-06-29 | 13G | ISEE / IVERIC bio Inc | 6,121,882 | |||||
| 2020-06-22 | 13D | RNA / Atrium Therapeutics, Inc. | 3,995,000 | |||||
| 2020-06-19 | 13G | CLDX / Celldex Therapeutics, Inc. | 1,885,000 | |||||
| 2020-06-11 | 13G | RLMD / Relmada Therapeutics, Inc. | 1,255,857 | |||||
| 2020-05-22 | 13G | OYST / Oyster Point Pharma Inc | 1,914,606 | |||||
| 2020-03-09 | 13D/A | DMTK / DermTech, Inc. | 2,449,769 | 2,658,627 | ||||
| 2020-02-26 | 13G/A | PHGE / BiomX Inc. | 900,000 | 900,000 | ||||
| 2020-02-14 | 13G/A | CNCE / Concert Pharmaceuticals Inc | 1,811,662 | 0 | ||||
| 2020-02-14 | 13G/A | 867328601 / Sunesis Pharmaceuticals, Inc. | 6,916,079 | 0 | ||||
| 2020-02-14 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 5,907,088 | 5,874,229 | ||||
| 2020-02-14 | 13G/A | AGEN / Agenus Inc. | 14,984,569 | 13,725,251 | ||||
| 2020-02-14 | 13G/A | ABUS / Arbutus Biopharma Corporation | 4,335,746 | 5,666,754 | ||||
| 2020-02-14 | 13G/A | MIST / Milestone Pharmaceuticals Inc. | 3,521,856 | 3,958,264 | ||||
| 2020-02-14 | 13G/A | AVDL / Avadel Pharmaceuticals plc | 3,396,155 | 3,401,434 | ||||
| 2020-02-14 | 13G/A | BLU / Bellus Health Inc | 4,840,992 | |||||
| 2020-02-14 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 6,256,840 | 6,386,607 | ||||
| 2020-02-14 | 13G/A | TELA / TELA Bio, Inc. | 1,151,458 | 1,139,358 | ||||
| 2020-02-14 | 13G/A | AXNX / Axonics, Inc. | 1,418,510 | 1,591,632 | ||||
| 2020-02-14 | 13G/A | PRQR / ProQR Therapeutics N.V. | 3,569,613 | 4,779,135 | ||||
| 2020-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,355,466 | 3,544,248 | ||||
| 2020-02-14 | 13G/A | FIXX / Homology Medicines, Inc. | 3,883,143 | 4,349,250 | ||||
| 2020-02-14 | 13G/A | ESTA / Establishment Labs Holdings Inc. | 1,054,091 | 2,032,446 | ||||
| 2020-02-14 | 13G/A | APYX / Apyx Medical Corporation | 2,391,898 | 3,391,279 | ||||
| 2020-02-14 | 13G/A | ARWR / Arrowhead Pharmaceuticals, Inc. | 5,316,156 | 0 | ||||
| 2020-02-14 | 13G/A | VIVE / Viveve Medical, Inc. | 4,480,565 | 0 | ||||
| 2020-02-14 | 13G/A | VCEL / Vericel Corporation | 2,289,134 | 2,989,429 | ||||
| 2020-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 2,274,369 | 2,551,020 | ||||
| 2020-02-14 | 13G | PTCT / PTC Therapeutics, Inc. | 1,922,346 | 3,832,480 | ||||
| 2020-02-14 | 13G | TBIO / Telesis Bio, Inc. | 3,304,808 | |||||
| 2020-02-14 | 13G/A | PTGX / Protagonist Therapeutics, Inc. | 2,186,657 | 2,459,988 | ||||
| 2020-02-14 | 13G/A | BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock) | 1,916,852 | |||||
| 2020-02-14 | 13G/A | US00448Q2012 / Achillion Pharmaceuticals, Inc. | 13,749,383 | 7,309,383 | ||||
| 2020-02-14 | 13G/A | SIBN / SI-BONE, Inc. | 1,234,118 | 0 | ||||
| 2020-02-14 | 13G/A | CLSD / Clearside Biomedical, Inc. | 3,747,699 | 3,750,107 | ||||
| 2020-02-14 | 13G/A | PHGE / BiomX Inc. | 900,000 | |||||
| 2020-01-27 | 13G | XGN / Exagen Inc. | 902,085 | |||||
| 2020-01-21 | 13G | WVE / Wave Life Sciences Ltd. | 2,414,027 | |||||
| 2019-12-30 | 13G | AVDL / Avadel Pharmaceuticals plc | 3,396,155 | |||||
| 2019-12-30 | 13G | FIXX / Homology Medicines, Inc. | 3,883,143 | |||||
| 2019-12-17 | 13G/A | TELA / TELA Bio, Inc. | 894,231 | 1,151,458 | ||||
| 2019-12-16 | 13G | PTGX / Protagonist Therapeutics, Inc. | 2,186,657 | |||||
| 2019-12-13 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 17,057,324 | 17,282,324 | ||||
| 2019-11-18 | 13G | TELA / TELA Bio, Inc. | 894,231 | |||||
| 2019-09-23 | 13G | CLSD / Clearside Biomedical, Inc. | 3,747,699 | |||||
| 2019-09-16 | 13G | BLUSF / BELLUS Health Inc. | 3,618,343 | |||||
| 2019-09-09 | 13D | DMTK / DermTech, Inc. | 2,449,769 | |||||
| 2019-09-09 | 13D | CNAC / Constellation Alpha Capital Corp. | 2,449,769 | |||||
| 2019-08-19 | 13G | BRSYF / BrainsWay Ltd. | 1,453,218 | |||||
| 2019-07-22 | 13G | 867328601 / Sunesis Pharmaceuticals, Inc. | 6,916,079 | |||||
| 2019-06-28 | 13G | STOK / Stoke Therapeutics, Inc. | 3,355,466 | |||||
| 2019-06-14 | 13G | LJPC / La Jolla Pharmaceutical Co. | 531,065 | 2,274,369 | ||||
| 2019-05-20 | 13G | MIST / Milestone Pharmaceuticals Inc. | 3,521,856 | |||||
| 2019-04-18 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 16,407,319 | 17,057,324 | ||||
| 2019-03-25 | 13G | CNCE / Concert Pharmaceuticals Inc | 1,811,662 | |||||
| 2019-02-22 | 13G | PRQR / ProQR Therapeutics N.V. | 448,141 | 3,569,613 | ||||
| 2019-02-15 | 13G | SIBN / SI-BONE, Inc. | 1,234,118 | |||||
| 2019-02-14 | 13G/A | APYX / Apyx Medical Corporation | 2,391,898 | |||||
| 2019-02-14 | 13G/A | US00448Q2012 / Achillion Pharmaceuticals, Inc. | 13,546,902 | 13,749,383 | ||||
| 2019-02-14 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 3,841,226 | 6,256,840 | ||||
| 2019-02-14 | 13G/A | AGEN / Agenus Inc. | 5,009,949 | 14,984,569 | ||||
| 2019-02-14 | 13G/A | APYX / Apyx Medical Corporation | 1,752,611 | 2,391,898 | ||||
| 2019-02-14 | 13G/A | CBIO / Crescent Biopharma, Inc. | 363,597 | 0 | ||||
| 2019-02-14 | 13G/A | ABUS / Arbutus Biopharma Corporation | 5,151,615 | 4,335,746 | ||||
| 2019-02-14 | 13G/A | ARWR / Arrowhead Pharmaceuticals, Inc. | 4,358,067 | 5,316,156 | ||||
| 2019-02-14 | 13G/A | CHAC.WS / Chardan Healthcare Acquisition Corp. | 600,000 | 600,000 | ||||
| 2019-02-14 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 5,035,662 | 5,907,088 | ||||
| 2019-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,326,199 | 531,065 | ||||
| 2019-02-14 | 13G/A | NVTR / Nuvectra Corporation | 737,619 | 0 | ||||
| 2019-02-14 | 13G/A | VCEL / Vericel Corporation | 1,758,914 | 2,289,134 | ||||
| 2019-02-14 | 13G/A | PRQR / ProQR Therapeutics N.V. | 1,903,158 | 448,141 | ||||
| 2019-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 4,130,115 | 1,922,346 | ||||
| 2019-02-14 | 13G/A | RGNX / REGENXBIO Inc. | 1,561,210 | 1,050,245 | ||||
| 2019-02-14 | 13G/A | VIVE / Viveve Medical, Inc. | 1,672,998 | 4,480,565 | ||||
| 2019-01-28 | 13G | AXNX / Axonics, Inc. | 1,418,510 | |||||
| 2019-01-18 | 13G | ESTA / Establishment Labs Holdings Inc. | 1,054,091 | |||||
| 2018-12-21 | 13G | CHAC.WS / Chardan Healthcare Acquisition Corp. | 600,000 | |||||
| 2018-11-29 | 13D/A | RCKT / Rocket Pharmaceuticals, Inc. | 16,407,319 | |||||
| 2018-11-16 | 13G | ADVM / Adverum Biotechnologies, Inc. | 3,841,226 | |||||
| 2018-09-17 | 13G | PRQR / ProQR Therapeutics N.V. | 1,903,158 | |||||
| 2018-05-14 | 13G | ARWR / Arrowhead Pharmaceuticals, Inc. | 4,358,067 | |||||
| 2018-05-14 | 13G | NVTR / Nuvectra Corporation | 737,619 | |||||
| 2018-03-05 | 13G | CORI / Corium International, Inc. | 1,699,653 | 1,910,522 | ||||
| 2018-02-14 | 13G/A | US00448Q2012 / Achillion Pharmaceuticals, Inc. | 7,096,936 | 13,546,902 | ||||
| 2018-02-14 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 2,043,216 | 5,035,662 | ||||
| 2018-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,349,066 | 1,326,199 | ||||
| 2018-02-14 | 13G/A | ABUS / Arbutus Biopharma Corporation | 2,770,284 | 5,151,615 | ||||
| 2018-02-14 | 13G/A | BCRX / BioCryst Pharmaceuticals, Inc. | 4,078,895 | 3,372,674 | ||||
| 2018-02-14 | 13G/A | VIVE / Viveve Medical, Inc. | 839,666 | 1,672,998 | ||||
| 2018-02-14 | 13G/A | RGNX / REGENXBIO Inc. | 1,547,885 | 1,561,210 | ||||
| 2018-02-14 | 13G/A | APYX / Apyx Medical Corporation | 1,682,611 | 1,752,611 | ||||
| 2018-02-14 | 13G/A | PTCT / PTC Therapeutics, Inc. | 1,794,336 | 4,130,115 | ||||
| 2018-02-14 | 13G/A | CORI / Corium International, Inc. | 1,461,447 | 1,699,653 | ||||
| 2018-02-12 | 13G | AGEN / Agenus Inc. | 5,009,949 | |||||
| 2018-02-05 | 13G | CBIO / Crescent Biopharma, Inc. | 313,264 | 363,597 | ||||
| 2018-01-18 | 13G | VCEL / Vericel Corporation | 1,758,914 | |||||
| 2018-01-16 | 13D | RCKT / Rocket Pharmaceuticals, Inc. | 15,439,557 | |||||
| 2018-01-16 | 13D | RCKT / Rocket Pharmaceuticals, Inc. | 15,439,557 | |||||
| 2018-01-09 | 13G | APYX / Apyx Medical Corporation | 1,682,611 | |||||
| 2017-10-05 | 13G | RGNX / REGENXBIO Inc. | 1,547,885 | |||||
| 2017-09-28 | 13G | US00448Q2012 / Achillion Pharmaceuticals, Inc. | 7,096,936 | |||||
| 2017-05-17 | 13G | ABUS / Arbutus Biopharma Corporation | 2,770,284 | |||||
| 2017-05-05 | 13G | CORI / Corium International, Inc. | 1,461,447 | |||||
| 2017-04-21 | 13G | PTCT / PTC Therapeutics, Inc. | 1,794,336 | |||||
| 2017-02-15 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 2,012,662 | 2,043,216 | ||||
| 2017-02-15 | 13G/A | BCRX / BioCryst Pharmaceuticals, Inc. | 3,701,460 | 4,078,895 | ||||
| 2017-02-15 | 13G/A | VIVE / Viveve Medical, Inc. | 4,753,806 | 839,666 | ||||
| 2017-02-15 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,347,445 | 1,349,066 | ||||
| 2016-08-26 | 13G | BCRX / BioCryst Pharmaceuticals, Inc. | 3,701,460 | |||||
| 2016-08-03 | 13G | SRTS / Sensus Healthcare, Inc. | 155,000 | 310,000 | ||||
| 2016-07-14 | 13G/A | SSRG / Symmetry Surgical Inc. | 879,623 | 0 | ||||
| 2016-06-13 | 13G | SRTS / Sensus Healthcare, Inc. | 155,000 | |||||
| 2016-02-11 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,347,445 | |||||
| 2016-02-09 | 13G/A | VIVE / Viveve Medical, Inc. | 3,591,378 | 4,753,806 | ||||
| 2016-02-09 | 13G/A | SSRG / Symmetry Surgical Inc. | 523,205 | 879,623 | ||||
| 2016-02-09 | 13G/A | DRNA / Dicerna Pharmaceuticals Inc | 2,012,662 | |||||
| 2016-02-09 | 13G/A | CBIO / Crescent Biopharma, Inc. | 0 | 313,264 | ||||
| 2015-10-02 | 13G | VIVE / Viveve Medical, Inc. | 3,591,378 | |||||
| 2015-06-03 | 13G | SSRG / Symmetry Surgical Inc. | 523,205 | |||||
| 2015-02-17 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,327,261 | |||||
| 2015-02-17 | 13G/A | TRGT / Targacept | 2,665,643 | |||||
| 2014-12-29 | 13G | DRNA / Dicerna Pharmaceuticals Inc | 1,115,981 | |||||
| 2014-10-03 | 13G/A | PHIO / Phio Pharmaceuticals Corp. | 0 | |||||
| 2014-06-11 | 13G | TRGT / Targacept | 1,930,407 | |||||
| 2014-05-28 | 13G | CHTP / Chelsea Therapeutics International, Ltd. | 4,299,722 | |||||
| 2014-02-14 | 13G/A | BCRX / BioCryst Pharmaceuticals, Inc. | 2,460,865 | |||||
| 2014-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 19,184,048 | |||||
| 2013-08-02 | 13G | BCRX / BioCryst Pharmaceuticals, Inc. | 2,728,709 | |||||
| 2013-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 1,489,878 | |||||
| 2013-01-18 | 13G | SOMX / Somaxon Pharmaceuticals, Inc. | 389,098 | |||||
| 2012-07-09 | 13G | PHIO / Phio Pharmaceuticals Corp. | 14,186,638 | |||||
| 2012-02-16 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 8,791,667 | |||||
| 2012-02-14 | 13G/A | LJPC / La Jolla Pharmaceutical Co. | 0 |